Download presentation
Presentation is loading. Please wait.
Published byCora Richardson Modified over 5 years ago
1
© The Author(s) 2015. Published by Science and Education Publishing.
Table 3. Intervention wise diabetic, lipid, hepatic & urinary profile in three phases of the study Parameters Baseline After 3 months intervention Washout period Overall effect within group Overall effect between group Placebo chromium P. value within group Chromium Picolinate Diabetic Profile FPG (mg/dl) 149.58 ±22.90 142.85 ±17.71 0.209 143.26 ±36.07 130.42 ±32.68 0.38 128.38 ±26.39 129.14 ±22.40 0.281 0.003 0.000 Insulin (µIU/mL) 24.47 ±16.49 33.37 ±28.3 0.394 22.66 ±12.01 24.72 ±23.2 0.472 20.18 ±11.88 24.33 ±22.7 0.474 0.037 HbA1C (%) 7.78 ±0.92 7.98 ±1.28 0.432 6.50 ±0.76 6.12 ±0.89 0.337 6.02 ±0.82 6.04 ±0.81 0.538 Lipid Profile Cholesterol 179.4 ±31.4 189.2 ±40.1 0.387 177 ±34.8 167±34 0.473 168 ±21.6 165.2 ±32.2 0.429 0.102 0.612 Triglyceride 180.4 ±83.1 193.2 ±158.4 0.418 192.2 ±71.3 148.4 ±46.3 0.323 163.54 ±34.14 163.50 ±45.7 0.131 0.923 HDL 38.2 ±9.2 38.6 ±12.8 0.445 43.4 ±11.07 42 ±11.4 0.446 46.4 ±10 44.6 ±11.5 0.613 0.645 0.565 LDL 109.5 ±30.2 111.7 ±42.4 0.335 104 ±29.8 98.1 ±38.6 0.489 103.8 ±24.03 97.09 ±46.1 0.363 0.119 0.861 VLDL 36.08 ±16.62 38.63 ±31.67 32.70 ±6.82 ±9.14 0.414 0.504 Hepatic Profile ALT (IU/L) 43.42 ±28.12 52.88 ±42.7 0.485 39.16 ±27.32 42.67 ±27.3 0.440 32 ±19.58 40.36 ±24.1 0.283 0.007 ALP 105.85 108.77 ±34.2 0.546 105.43 ±31.42 92.64 109 ±33.13 84 ±19.5 0.428 0.025 Urinary Profile UMA (mg) 24.34 ±24.84 25.17 ±27.7 26.82 ±43.48 26.11 ±27.5 28.83 ±43.46 24.94 ±26.8 0.420 0.393 0.999 Urinary Protein 32.84 ±30.30 106.5 ±336 0.434 20.28 ±17.57 50.46 ±62.4 0.395 27.3 ±16.8 19.34 ±10.4 0.301 0.450 Urinary creatinine (mg/dL) 112.4 ±61.01 126.8 ±86.3 0.433 93.63 ±55.73 83.91 ±60.3 0.476 108 ±48.8 119.2 ±54.2 0.392 0.215 0.099 FPG= Fasting Plasma Glucose, HbA1C= Glycated Hemoglobin, HDL = High Density Lipoprotein, LDL = Low Density Lipoprotein, VLDL = Very Low Density Lipoprotein, UMA =Urinary Micro Albumin Hajra Ahmad et al. Effect of Chromium Picolinate Supplementation on Diabetic Profile and Nutritional Status of the Type-2 Diabetic Adult Population – A Randomized Controlled Trial. Journal of Food and Nutrition Research, 2016, Vol. 4, No. 8, doi: /jfnr-4-8-8 © The Author(s) Published by Science and Education Publishing.
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.